Jessica Hopfield

Chairman

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jessica Hopfield

Jessica Hopfield is recorded as Chairman at Editas Medicine, Inc. (EDIT). Editas Medicine, Inc. reported in an 8-K filed December 12, 2024 that Jessica Hopfield was appointed Chair of the Board, effective December 31, 2024.

“Jessica Hopfield, Ph.D., has been named Chair of the Board, effective December 31, 2024.”

Editas Medicine, Inc. Form 8-K, filed December 12, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Jessica Hopfield's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Editas Medicine, Inc. (EDIT)
Chairman

SEC 8-K

Current
2024-12-31–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Editas Medicine, Inc.

EDIT

Current role

Chairman

2024-12-31–present

Leadership on record at Editas Medicine, Inc.

Other people whose current roles at this company are on record from its filings.

Gilmore O'Neill, M.B., M.M.Sc. CEO, Board Member
James C. Mullen CEO
Katrine S. Bosley CEO
Amy Parison CFO
Andrew A. F. Hack CFO
Eric Ek CFO
Erick J. Lucera CFO
Vic Myer CTO
Bernadette Connaughton Board Member
David Scadden, M.D. Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Chair of the Board Editas Medicine, Inc. (EDIT)
2024-12-31